Immunovant, Inc.
IMVT
$15.80
-$0.06-0.38%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 12.37% | -45.77% | 75.21% | 69.72% | 68.74% |
Total Receivables | -54.37% | 116.13% | 32.02% | 193.68% | 521.81% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 105.53% | 89.43% | 64.19% | 38.44% | -7.48% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 15.30% | -41.96% | 74.25% | 68.29% | 64.66% |
|
|||||
Total Current Assets | 15.30% | -41.96% | 74.25% | 68.29% | 64.66% |
Net Property, Plant & Equipment | 58.32% | 15.52% | -19.82% | -47.72% | -60.47% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 16.49% | -40.83% | 76.57% | 67.89% | 64.19% |
|
|||||
Total Accounts Payable | 146.76% | 406.80% | 175.96% | -58.29% | 428.82% |
Total Accrued Expenses | 22.88% | 73.84% | 42.77% | 41.43% | 2.17% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -28.99% | -92.48% | -92.35% | -92.49% | -88.24% |
Total Finance Division Other Current Liabilities | 1,720.00% | -- | -- | -- | -95.71% |
Total Other Current Liabilities | 1,720.00% | -- | -- | -- | -95.71% |
Total Current Liabilities | 41.49% | 112.81% | 65.56% | -12.34% | 12.27% |
|
|||||
Total Current Liabilities | 41.49% | 112.81% | 65.56% | -12.34% | 12.27% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 41.49% | 112.81% | 65.56% | -12.34% | 12.14% |
|
|||||
Common Stock & APIC | 34.96% | 3.70% | 54.60% | 54.93% | 55.34% |
Retained Earnings | -50.12% | -51.00% | -46.21% | -42.57% | -45.79% |
Treasury Stock & Other | -23.53% | 513.17% | 272.32% | 212.71% | 123.94% |
Total Common Equity | 14.52% | -48.09% | 78.33% | 81.64% | 70.42% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 14.52% | -48.09% | 78.33% | 81.64% | 70.42% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 14.52% | -48.09% | 78.33% | 81.64% | 70.42% |
|